Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Business

Nestle to launch frozen pizzas, other foods targeting users of weight-loss drugs

by May 22, 2024
May 22, 2024
Nestle to launch frozen pizzas, other foods targeting users of weight-loss drugs

Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy.

Over the last year, the buzzy weight loss and diabetes drugs have taken off as more options hit the market and celebrities like Oprah Winfrey and Elon Musk endorse them. Roughly 1 in 8 adults in the U.S. has used a GLP-1 drug at some point, according to a recent survey from the health policy research organization KFF. Roughly half of those Americans, or around 6% of U.S. adults, are currently using one of the treatments. The total number of U.S. consumers taking the medication could soar to 31.5 million, or 9% of the total population, by 2035, according to Morgan Stanley research.

As the drugs’ popularity has soared, investors have grown concerned about what their rise means for food and beverage companies and fast-food chains. People who take the medication typically eat less frequently because they have fewer cravings and desire more protein and less sugary and fatty foods. In October, Walmart’s U.S. CEO John Furner told Bloomberg that people who pick up GLP-1 drugs from its pharmacies are buying less food, typically with fewer calories.

But Nestle sees an opportunity to cater to those consumers through Vital Pursuit.

“The reality is, for the last 25 years, the diet has been dying, in a sense. … For me, what we’ve done is actually given consumers a new tool that actually gives them confidence and success on this journey,” Nestle’s North America CEO Steve Presley told CNBC.

The new brand’s initial lineup of 12 items will include frozen bowls with whole grains or protein-packed pasta, along with sandwich melts and pizzas. The products will include one or more essential nutrients, like protein, calcium or iron. The company plans to sell Vital Pursuit items for $4.99 or under and offer gluten-free options.

Vital Pursuit’s packaging won’t include mentions of GLP-1 medications, but Nestle said the company will more directly connect the brand to the drugs on social media.

The new line will hit the freezer aisle by the fourth quarter.

In recent years, Nestle has also tried to focus more on health-conscious consumers. In 2018, it sold its U.S. candy business, which includes brands like Butterfinger, Crunch and Laffy Taffy, to Ferrero for $2.8 billion. Nestle’s food business, which includes brands like Stouffer’s and Toll House, only accounts for 14.5% of its U.S. sales.

Nestle already owns Lean Cuisine, which was founded in 1981 as a healthier alternative to other frozen meals. But the company chose to create a new brand to reach GLP-1 users because Lean’s branding focuses on consumers looking to limit their calories. But people who take GLP-1 medications may want to consume more nutrients, like protein, which can help with the muscle loss associated with the drugs. 

“The consumer research shows that there are certain nutrients and certain macros that need to be delivered to actually help the consumers stay healthy along the journey of the GLP-1 treatment,” Presley said.

Shares of Swiss-based Nestle have fallen 16% this year, dragging its market value down to $278 billion. The food company expects that its global growth will slow this year as inflation-weary consumers buy less of its products.

This post appeared first on NBC NEWS
previous post
Hims & Hers Health says it will offer compounded GLP-1 injections
next post
Trump Media lost $327.6 million in the first quarter of the year on revenue of just $770,500

Related Posts

Apple looking to make ‘premium’-priced folding iPhones starting...

June 20, 2025

Last-minute summer travelers are finding the best deals...

August 12, 2024

Trump transfers all his DJT shares to his...

December 20, 2024

Gold bars are selling like hot cakes in...

May 10, 2024

Employers added 206,000 jobs in June as sturdy...

July 8, 2024

Walgreens announces price cuts on 1,300 items amid...

May 30, 2024

A rare high-performance Cadillac that once belonged to...

February 16, 2024

Richard Parsons, former Time Warner CEO, dies at...

December 27, 2024

Some Walmart garment orders from Bangladesh on hold...

July 13, 2025

Former Disney CEO Bob Chapek breaks silence, says...

March 25, 2024

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Trump closes out 30th week in office with ‘very warm’ high-stakes Putin meeting

      August 16, 2025
    • State Department stops issuing all visitor visas for individuals from Gaza

      August 16, 2025
    • Zelenskyy outlines peace demands before high-stakes White House meeting with Trump

      August 16, 2025
    • Putin backs Trump’s claim that the Ukraine war would not have happened if he’d won 2020 election

      August 16, 2025
    • ROBERT MAGINNIS: What comes next for US, Russia and Ukraine after Alaska summit

      August 16, 2025
    • Zelenskyy to meet with Trump in Washington, DC following US-Russia talks

      August 16, 2025

    Categories

    • Business (1,350)
    • Politics (6,757)
    • Stocks (904)
    • World News (461)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved